Tyra Biosciences, Inc. TYRA Balance Sheet Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| $77.39M-15.9% | $91.97M+58.5% | $58.01M-76.9% | $251.21M-16.9% | ||
| $1M0.0% | $1M0.0% | $1M0.0% | $1M+312% | ||
| $9.45M+56.9% | $6.02M-26.6% | $8.2M+35.0% | $6.08M+224% | ||
| $265.45M-23.6% | $347.46M+64.2% | $211.67M-17.7% | $257.29M-15.4% | ||
| $1.31M-20.4% | $1.65M+1.4% | $1.63M+51.2% | $1.08M+4.9% | ||
| $9.27M+25.7% | $7.38M+46.6% | $5.03M+15.7% | $4.35M+1,294% | ||
| $282.61M-22.3% | $363.56M+61.0% | $225.86M-15.1% | $266.18M-13.2% | ||
| $1.18M+99.7% | $590K-87.3% | $4.66M+307% | $1.15M+91.2% | ||
| $16.44M+21.0% | $13.59M+30.8% | $10.39M+135% | $4.42M+56.9% | ||
| $472K+14.6% | $412K+47.1% | $280K+100% | $140K-30.7% | ||
| $18.09M+24.0% | $14.59M-4.8% | $15.33M+169% | $5.7M+57.7% | ||
| $5.34M-8.1% | $5.81M-6.5% | $6.22M+150% | $2.48M+153% | ||
| $5.81M-6.6% | $6.22M-4.2% | $6.5M+148% | $2.62M+122% | ||
| $23.43M+14.8% | $20.41M-5.5% | $21.6M+159% | $8.35M+68.3% | ||
| $0— | $0— | $0— | $0— | ||
| $5K0.0% | $5K+25.0% | $4K0.0% | $4K0.0% | ||
| $630.04M+6.1% | $593.69M+61.0% | $368.71M+4.3% | $353.52M+3.3% | ||
| -$371.26M-47.7% | -$251.31M-52.5% | -$164.83M-72.2% | -$95.7M-137% | ||
| $393K-49.0% | $770K+102% | $381K— | $0— | ||
| $259.18M-24.5% | $343.15M+68.0% | $204.26M-20.8% | $257.83M-14.6% | ||
| $282.61M-22.3% | $363.56M+61.0% | $225.86M-15.1% | $266.18M-13.2% | ||
| $9.27M+25.7% | $7.38M+46.6% | $5.03M+15.7% | $4.35M+1,294% | ||
| $9.27M+25.7% | $7.38M+46.6% | $5.03M+15.7% | $4.35M+1,294% | ||
| $5.57M-8.2% | $6.07M-7.0% | $6.53M+165% | $2.47M+132% | ||
| $9.27M+25.7% | $7.38M+46.6% | $5.03M+15.7% | $4.35M+1,294% | ||
| $5.81M-6.6% | $6.22M-4.2% | $6.5M+148% | $2.62M+122% | ||
| $630.04M+6.1% | $593.69M+61.0% | $368.71M+4.3% | $353.52M+3.3% | ||
| $5K0.0% | $5K+25.0% | $4K0.0% | $4K0.0% | ||
| $0— | $0— | $0— | $0— | ||
| $16.44M+21.0% | $13.59M+30.8% | $10.39M+135% | $4.42M+56.9% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Tyra Biosciences, Inc.'s total assets?
- Tyra Biosciences, Inc. (TYRA) holds $412.0M in total assets, up 20.0% year over year.
- How much debt does Tyra Biosciences, Inc. have?
- Tyra Biosciences, Inc. carries $5.7M in total debt against $387.6M of shareholders' equity, a debt-to-equity ratio of 0.01.
- How much cash does Tyra Biosciences, Inc. have?
- Tyra Biosciences, Inc. holds $85.0M in cash and equivalents.
- Can Tyra Biosciences, Inc. cover its short-term obligations?
- Its current ratio is 20.49 — current assets exceed current liabilities.
- Where does Tyra Biosciences, Inc.'s balance sheet data come from?
- Every line is extracted from Tyra Biosciences, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.